23-06-29 Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023 CI
23-03-28 Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023 CI
23-01-16 Advanced Proteome Therapeutics Corporation agreed to Spin-Off Linceis Capital Corp. CI
22-12-22 Advanced Proteome Therapeutics Corporation announced that it has received CAD 0.0725 million in funding from Conation Capital CI
22-12-21 Advanced Proteome Therapeutics Corporation Reports Earnings Results for the First Quarter Ended October 31, 2022 CI
22-11-20 Advanced Proteome Therapeutics Corporation Appoints Mr. Cory Brandolini to the Board of Directors CI
22-11-14 Advanced Proteome Therapeutics Corporation Auditor Raises 'Going Concern' Doubt CI
22-11-14 Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Full Year Ended July 31, 2022 CI
22-06-28 Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022 CI
22-04-13 Advanced Proteome Therapeutics up 28.5%, Receives Notice of Allowance for Patent Claims MT
22-03-25 Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2022 CI
21-12-17 Advanced Proteome Therapeutics Corporation Reports Earnings Results for the First Quarter Ended October 31, 2021 CI
21-11-28 Advanced Proteome Therapeutics Corporation Auditor Raises 'Going Concern' Doubt CI
Manager TitleAgeSince
Chief Executive Officer 65 2018-11-30
Director of Finance/CFO 74 2009-03-09
Director TitleAgeSince
Director/Board Member 58 2018-12-19
Director/Board Member 61 2007-05-10
Director/Board Member 65 2018-04-15
Change 5-day change 1-year change 3-year change Capi.($)
+2.41%-.--% - - 149K
-1.93%+16.24%-53.83% - 14.52B
+11.61%-2.02%+5.49% - 1.24B
+11.62%+12.76% - - 862M
-1.62%-10.09%+262.44%-69.24% 609M
+1.13%-0.28% - - 604M
-0.10%-0.20% - - 596M
-0.10%-0.38% - - 594M
+5.42%+1.33% - - 599M
Average +3.16%+2.17%+71.37%-69.24% 2.45B
Weighted average by Cap. -0.04%+12.15%-37.56%-69.24%
Logo Advanced Proteome Therapeutics Corp.
Advanced Proteome Therapeutics Corporation is actively seeking additional funds to advance its core technologies for partnering and other potential revenue streams. It is not engaged in any activity.
Employees
-